Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease

Journal of Ophthalmology

Volumn 2015, Issue , 2015, Pages

  Scripsema, Nicole K ^a   Hu, Dan Ning ^a,b   Rosen, Richard B ^a,b  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84954435852     PISSN: 2090004X     EISSN: 20900058     Source Type: Journal    
DOI: 10.1155/2015/865179     Document Type: Review

References (142)

1. H. M. Rasmussen, T. Muzhingi, E. M. R. Eggert, and E. J. Johnson, "Lutein, zeaxanthin, meso-zeaxanthin content in egg yolk and their absence in fish and seafood," Journal of Food Composition and Analysis, vol. 27, no. 2, pp. 139-144, 2012.
2. O. Sommerburg, J. E. E. Keunen, A. C. Bird, and F. J. G. M. van Kuijk, "Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes," The British Journal of Ophthalmology, vol. 82, no. 8, pp. 907-910, 1998.
3. W. Schalch, "Carotenoids in the retina-a review of their possible role in preventing or limiting damage caused by light and oxygen," EXS, vol. 62, pp. 280-298, 1992.
4. P. S. Bernstein, F. Khachik, L. S. Carvalho, G. J. Muir, D.-Y. Zhao, and N. B. Katz, "Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye," Experimental Eye Research, vol. 72, no. 3, pp. 215-223, 2001.
5. G. J. Handelman, D. M. Snodderly, A. J. Adler, M. D. Russett, and E. A. Dratz, "Measurement of carotenoids in human and monkey retinas," in Methods in Enzymology, vol. 213, pp. 220-230, Academic Press, New York, NY, USA, 1992.
6. F. Granado, B. Olmedilla, and I. Blanco, "Nutritional and clinical relevance of lutein in human health," The British Journal of Nutrition, vol. 90, no. 3, pp. 487-502, 2003.
7. R. A. Bone, J. T. Landrum, G.W. Hime, A. Cains, and J. Zamor, "Stereochemistry of the human macular carotenoids," Investigative Ophthalmology & Visual Science, vol. 34, no. 6, pp. 2033-2040, 1993.
8. D.M. Snodderly, G. J. Handelman, and A. J. Adler, "Distribution of individual macular pigment carotenoids in central retina of macaque and squirrelmonkeys," Investigative Ophthalmology & Visual Science, vol. 32, no. 2, pp. 268-279, 1991.
9. R. A. Bone, J. T. Landrum, L. Fernandez, and S. L. Tarsis, "Analysis of the macular pigment by HPLC: retinal distribution and age study," Investigative Ophthalmology and Visual Science, vol. 29, no. 6, pp. 843-849, 1988.
10. R. A. Bone, J. T. Landrum, L. M. Friedes et al., "Distribution of lutein and zeaxanthin stereoisomers in the human retina," Experimental Eye Research, vol. 64, no. 2, pp. 211-218, 1997.
11. R. A. Bone, J. T. Landrum, Y. Cao, A.N. Howard, and F. Alvarez-Calderon, "Macular pigment response to a supplement containing-meso-zeaxanthin, lutein and zeaxanthin," Nutrition&Metabolism, vol. 4, article 12, 2007.
12. K. O. Akuffo, J. M. Nolan, A. N. Howard et al., "Sustained supplementation andmonitored responsewith differing carotenoid formulations in early age-related macular degeneration," Eye (London, UK), vol. 29, no. 7, pp. 902-912, 2015.
13. D.M. Snodderly, J.D. Auran, and F. C. Delori, "Themacularpigment. II. Spatial distribution in primate retinas," Investigative Ophthalmology & Visual Science, vol. 25, no. 6, pp. 674-685, 1984.
14. W. T. Ham Jr., H. A. Mueller, and D. H. Sliney, "Retinal sensitivity to damage from short wavelength light," Nature, vol. 260, no. 5547, pp. 153-155, 1976.
15. C. B. Y. Kim and M. J. Mayer, "Foveal flicker sensitivity in healthy aging eyes. II. Cross-sectional aging trends from 18 through 77 years of age," Journal of the Optical Societyof America A: Optics and Image Science, and Vision, vol. 11, no. 7, pp. 1958-1969, 1994.
16. L. M. Renzi and B. R. Hammond, "The effect of macular pigment on heterochromatic luminance contrast," Experimental Eye Research, vol. 91, no. 6, pp. 896-900, 2010.
17. S. Richer, W. Stiles, L. Statkute et al., "Double-masked, placebocontrolled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial)," Optometry, vol. 75, no. 4, pp. 216-230, 2004.
18. S. Beatty, H.-H. Koh, M. Phil, D. Henson, and M. Boulton, "The role of oxidative stress in the pathogenesis of age-related macular degeneration," Survey of Ophthalmology, vol. 45, no. 2, pp. 115-134, 2000.
19. O. G. Sommerburg, W. G. Siems, J. S. Hurst, J. W. Lewis, D. S. Kliger, and F. J. G. M. van Kuijk, "Lutein and zeaxanthin are associated with photoreceptors in the human retina," Current Eye Research, vol. 19, no. 6, pp. 491-495, 1999.
20. W. Stahl and H. Sies, "Antioxidant effects of carotenoids: implication in photoprotection in humans," in Handbook of Antioxidants, E. Cadenas and L. Packer, Eds., pp. 223-233, Marcel Dekker, New York, NY, USA, 2002.
21. K. Fukuzawa, Y. Inokami, A. Tokumura, J. Terao, and A. Suzuki, "Rate constants for quenching singlet oxygen and activities for inhibiting lipid peroxidation of carotenoids and α-tocopherol in liposomes," Lipids, vol. 33, no. 8, pp. 751-756, 1998.
22. R. J. Cogdell, T. G. Monger, and W. W. Parson, "Carotenoid triplet states in reaction centers from Rhodopseudomonas sphaeroides and Rhodospirillum rubrum," Biochimica et Biophysica Acta (BBA)-Bioenergetics, vol. 408, no. 3, pp. 189-199, 1975.
23. P. Di Mascio, S. Kaiser, and H. Sies, "Lycopene as the most efficient biological carotenoid singlet oxygen quencher," Archives of Biochemistry and Biophysics, vol. 274, no. 2, pp. 532-538, 1989.
24. K. Jørgensen and L. H. Skibsted, "Carotenoid scavenging of radicals. Effect of carotenoid structure and oxygen partial pressure on antioxidative activity," Zeitschrift für Lebensmittel-Untersuchung Und -Forschung, vol. 196, no. 5, pp. 423-429, 1993.
25. N. I. Krinsky, "Carotenoid protection against oxidation," Pure and Applied Chemistry, vol. 51, no. 3, pp. 649-660, 1979.
26. N. I. Krinsky and S. M. Deneke, "Interaction of oxygen and oxy-radicals with carotenoids," Journal of the National Cancer Institute, vol. 69, no. 1, pp. 205-210, 1982.
27. B. P. Lim, A. Nagao, J. Terao, K. Tanaka, T. Suzuki, and K. Takama, "Antioxidant activity of xanthophylls on peroxyl radical-mediated phospholipid peroxidation," Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism, vol. 1126, no. 2, pp. 178-184, 1992.
28. S. E. G. Nilsson, S. P. Sundelin, U. Wihlmark, and U. T. Brunk, "Aging of cultured retinal pigment epithelial cells: oxidative reactions, lipofuscin formation and blue light damage," Documenta Ophthalmologica, vol. 106, no. 1, pp. 13-16, 2003.
29. E. J. Johnson, "The role of carotenoids in human health," Nutrition in Clinical Care, vol. 5, no. 2, pp. 56-65, 2002.
30. S. R. Kim, K. Nakanishi, Y. Itagaki, and J. R. Sparrow, "Photooxidation of A2-PE, a photoreceptor outer segment fluorophore, and protection by lutein and zeaxanthin," Experimental Eye Research, vol. 82, no. 5, pp. 828-839, 2006.
31. G. J. Handelman, E. A. Dratz, C. C. Reay, and F. J. G. M. van Kuijk, "Carotenoids in the human macula and whole retina," Investigative Ophthalmology & Visual Science, vol. 29, no. 6, pp. 850-855, 1988.
32. A. Junghans, H. Sies, and W. Stahl, "Macular pigments lutein and zeaxanthin as blue light filters studied in liposomes," Archives of Biochemistry and Biophysics, vol. 391, no. 2, pp. 160-164, 2001.
33. A. Sujak, J. Gabrielska, W. Grudziński, R. Borc, P. Mazurek, and W. I. Gruszecki, "Lutein and zeaxanthin as protectors of lipid membranes against oxidative damage: the structural aspects," Archives of Biochemistry and Biophysics, vol. 371, no. 2, pp. 301-307, 1999.
34. J. M. Stringham, K. Fuld, and A. J. Wenzel, "Action spectrum for photophobia," Journal of the Optical Society of America A: Optics, Image Science, and Vision, vol. 20, no. 10, pp. 1852-1858, 2003.
35. J. M. Stringham, K. Fuld, and A. J. Wenzel, "Spatial properties of photophobia," Investigative Ophthalmology & Visual Science, vol. 45, no. 10, pp. 3838-3848, 2004.
36. A. J. Wenzel, K. Fuld, J. M. Stringham, and J. Curran-Celentano, "Macular pigment optical density and photophobia light threshold," Vision Research, vol. 46, no. 28, pp. 4615-4622, 2006.
37. J. M. Stringham and B. R. Hammond Jr., "The glare hypothesis of macular pigment function," Optometry and Vision Science, vol. 84, no. 9, pp. 859-864, 2007.
38. J. M. Stringham and B. R. Hammond, "Macular pigment and visual performance under glare conditions," Optometry and Vision Science, vol. 85, no. 2, pp. 82-88, 2008.
39. J. M. Stringham, E. R. Bovier, J. C. Wong, and B. R. Hammond Jr., "The influence of dietary lutein and zeaxanthin on visual performance," Journal of Food Science, vol. 75, no. 1, pp. R24-R29, 2010.
40. J. M. Stringham, P. V. Garcia, P. A. Smith, L. N. McLin, and B. K. Foutch, "Macular pigment and visual performance in glare: benefits for photostress recovery, disability glare, and visual discomfort," Investigative Ophthalmology & Visual Science, vol. 52, no. 10, pp. 7406-7415, 2011.
41. B. R. Hammond, L. M. Fletcher, F. Roos, J. Wittwer, and W. Schalch, "A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast," Investigative Ophthalmology &Visual Science, vol. 55, no. 12, pp. 8583-8589, 2014.
42. S. Beatty, U. Chakravarthy, J. M. Nolan et al., "Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration," Ophthalmology, vol. 120, no. 3, pp. 600-606, 2013.
43. J. Dawczynski, S. Jentsch, D. Schweitzer, M. Hammer, G. E. Lang, and J. Strobel, "Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGAstudy," Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 251, no. 12, pp. 2711-2723, 2013.
44. L. Ma, S.-F. Yan, Y.-M. Huang et al., "Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration," Ophthalmology, vol. 119, no. 11, pp. 2290-2297, 2012.
45. I. J. Murray, M. Makridaki, R. L. P. van der Veen, D. Carden, N. R.A. Parry, and T. T. J. M. Berendschot, "Lutein supplementation over a one-year period in early AMD might have a mild beneficial effect on visual acuity: the CLEAR study," Investigative Ophthalmology & Visual Science, vol. 54, no. 3, pp. 1781-1788, 2013.
46. S. Piermarocchi, S. Saviano, V. Parisi et al., "Carotenoids in Age-Related Maculopathy Italian Study (CARMIS): two-year results of a randomized study," European Journal of Ophthalmology, vol. 22, no. 2, pp. 216-225, 2012.
47. G. Weigert, S. Kaya, B. Pemp et al., "Effects of lutein supplementation onmacular pigment optical density and visual acuity in patients with age-relatedmacular degeneration," Investigative Ophthalmology & Visual Science, vol. 52, no. 11, pp. 8174-8178, 2011.
48. J. M. Nolan, J. Loughman, M. C. Akkali et al., "The impact of macular pigment augmentation on visual performance in normal subjects: COMPASS," Vision Research, vol. 51, no. 5, pp. 459-469, 2011.
49. B. R. Hammond Jr. and B. R. Wooten, "CFF thresholds: relation to macular pigment optical density," Ophthalmic and Physiological Optics, vol. 25, no. 4, pp. 315-319, 2005.
50. E. D. Brown, M. S. Micozzi, N. E. Craft et al., "Plasma carotenoids in normal men after a single ingestion of vegetables or purified β-carotene,"The American Journal of Clinical Nutrition, vol. 49, no. 6, pp. 1258-1265, 1989.
51. L. Chasan-Taber, W. C. Willett, J. M. Seddon et al., "A prospective study of carotenoid and Vitamin A intakes and risk of cataract extraction in US women," The American Journal of Clinical Nutrition, vol. 70, no. 4, pp. 509-516, 1999.
52. B. R. Hammond Jr., B. R. Wooten, and D. M. Snodderly, "Density of the human crystalline lens is related to the macular pigment carotenoids, lutein and zeaxanthin," Optometry and Vision Science, vol. 74, no. 7, pp. 499-504, 1997.
53. N. E. Craft, T. B. Haitema, K. M. Garnett, K. A. Fitch, and C.K. Dorey, "Carotenoid, tocopherol, and retinol concentrations in elderly human brain," Journal of Nutrition, Health & Aging, vol. 8, no. 3, pp. 156-162, 2004.
54. E. J. Berrow, H. E. Bartlett, F. Eperjesi, and J. M. Gibson, "The effects of a lutein-based supplement on objective and subjective measures of retinal and visual function in eyes with age-related maculopathy-a randomised controlled trial," The British Journal of Nutrition, vol. 109, no. 11, pp. 2008-2014, 2013.
55. L. Ma, H.-L. Dou, Y.-M. Huang et al., "Improvement of retinal function in early age-related macular degeneration after Lutein and zeaxanthin supplementation: a randomized, doublemasked, placebo-controlled trial," American Journal of Ophthalmology, vol. 154, no. 4, pp. 625.e1-634.e1, 2012.
56. E. J. Johnson, B. R. Hammond, K.-J. Yeum et al., "Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density," The American Journal of Clinical Nutrition, vol. 71, no. 6, pp. 1555-1562, 2000.
57. R. Vishwanathan, A. Iannaccone, T. M. Scott et al., "Macular pigment optical density is related to cognitive function in older people," Age and Ageing, vol. 43, no. 2, Article IDaft210, pp. 271-275, 2014.
58. R. Vishwanathan, M. Neuringer, D. Max Snodderly, W. Schalch, and E. J. Johnson, "Macular lutein and zeaxanthin are related to brain lutein and zeaxanthin in primates," Nutritional Neuroscience, vol. 16, no. 1, pp. 21-29, 2013.
59. J. Feeney, C. Finucane, G. M. Savva et al., "Lowmacular pigment optical density is associated with lower cognitive performance in a large, population-based sample of older adults," Neurobiology of Aging, vol. 34, no. 11, pp. 2449-2456, 2013.
60. E. J. Johnson, K. McDonald, S. M. Caldarella, H.-Y. Chung, A. M. Troen, and D.M. Snodderly, "Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women," Nutritional Neuroscience, vol. 11, no. 2, pp. 75-83, 2008.
61. L. M. Renzi, M. J. Dengler, A. Puente, L. S. Miller, and B. R. Hammond Jr., "Relationships between macular pigment optical density and cognitive function in unimpaired andmildly cognitively impaired older adults," Neurobiology of Aging, vol. 35, no. 7, pp. 1695-1699, 2014.
62. E. R. Bovier, L.M. Renzi, and B. R. Hammond, "A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on neural processing speed and efficiency," PLoS ONE, vol. 9, no. 9, Article ID e108178, 2014.
63. J. S. Bertram, "Carotenoids and gene regulation," Nutrition Reviews, vol. 57, no. 6, pp. 182-191, 1999.
64. H. Sies and W. Stahl, "Carotenoids and intercellular communication via gap junctions," International Journal for Vitamin and Nutrition Research, vol. 67, no. 5, pp. 364-367, 1997.
65. W. Stahl, S. Nicolai, K. Briviba et al., "Biological activities of natural and synthetic carotenoids: induction of gap junctional communication and singlet oxygen quenching," Carcinogenesis, vol. 18, no. 1, pp. 89-92, 1997.
66. N. Congdon, B. O'Colmain, C. C. Klaver et al., "Causes and prevalence of visual impairment among adults in the United States," Archives of Ophthalmology, vol. 122, no. 4, pp. 477-485, 2004.
67. L. Ma, H.-L. Dou, Y.-Q. Wu et al., "Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis,"The British Journal of Nutrition, vol. 107, no. 3, pp. 350-359, 2012.
68. E. Cho, S. E. Hankinson, B. Rosner, W. C. Willett, and G. A. Colditz, "Prospective study of lutein/zeaxanthin intake and risk of age-related macular degeneration," The American Journal of Clinical Nutrition, vol. 87, no. 6, pp. 1837-1843, 2008.
69. J. S. L. Tan, J. J. Wang, V. Flood, E. Rochtchina, W. Smith, and P. Mitchell, "Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye study," Ophthalmology, vol. 115, no. 2, pp. 334-341, 2008.
70. S.M. Moeller, N. Parekh, L. Tinker et al., "Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-Related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative," Archives of Ophthalmology, vol. 124, no. 8, pp. 1151-1162, 2006.
71. R. van Leeuwen, S. Boekhoorn, J. R. Vingerling et al., "Dietary intake of antioxidants and risk of age-related macular degeneration," Journal of the American Medical Association, vol. 294, no. 24, pp. 3101-3107, 2005.
72. G. M. Vanden Langenberg, J. A. Mares-Perlman, R. Klein, B. E. K. Klein, W. E. Brady, and M. Palta, "Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the beaver dam eye study," American Journal of Epidemiology, vol. 148, no. 2, pp. 204-214, 1998.
73. J. M. Seddon, U. A. Ajani, R.D. Sperduto et al., "Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration,"The Journal of the American Medical Association, vol. 272, no. 18, pp. 1413-1420, 1994.
74. J. P. San Giovanni, E. Y. Chew, T. E. Clemons et al., "The relationship of dietary carotenoid and Vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS report No. 22," Archives of Ophthalmology, vol. 125, no. 9, pp. 1225-1232, 2007.
75. L. Ho, R. van Leeuwen, J. C. M. Witteman et al., "Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and ω-3 fatty acids: the Rotterdam study," Archives of Ophthalmology, vol. 129, no. 6, pp. 758-766, 2011.
76. J. A. Mares-Perlman, W. E. Brady, R. Klein et al., "Serumantioxidants and age-related macular degeneration in a populationbased case-control study," Archives of Ophthalmology, vol. 113, no. 12, pp. 1518-1523, 1995.
77. C. R. Gale, N. F. Hall, D. I. W. Phillips, and C. N. Martyn, "Lutein and zeaxanthin status and risk of age-related macular degeneration," Investigative Ophthalmology & Visual Science, vol. 44, no. 6, pp. 2461-2465, 2003.
78. R. A. Bone, J. T. Landrum, and S. L. Tarsis, "Preliminary identification of the human macular pigment," Vision Research, vol. 25, no. 11, pp. 1531-1535, 1985.
79. R. A. Bone, J. T. Landrum, S. T. Mayne, C. M. Gomez, S. E. Tibor, and E. E. Twaroska, "Macular pigment in donor eyes with andwithout AMD: a case-control study," Investigative Ophthalmology & Visual Science, vol. 42, no. 1, pp. 235-240, 2001.
80. B. R. Hammond and B. R. Wooten, "Comments on the use of Raman spectroscopy for the in vivo measurement of human macular pigment," Applied Spectroscopy, vol. 60, no. 11, pp. 1348-1351, 2006.
81. R. L. P. van der Veen, T. T. J. M. Berendschot, M. Makridaki, F. Hendrikse, D. Carden, and I. J. Murray, "Correspondence between retinal reflectometry and a flicker-based technique in the measurement of macular pigment spatial profiles," Journal of Biomedical Optics, vol. 14, no. 6, Article ID064046, 2009.
82. B. R. Hammond Jr., J. Curran-Celentano, S. Judd et al., "Sex differences in macular pigment optical density: relation to plasma carotenoid concentrations and dietary patterns," Vision Research, vol. 36, no. 13, pp. 2001-2012, 1996.
83. J. M. Nolan, R. Kenny, C. O'Regan et al., "Macular pigment optical density in an ageing Irish population: the Irish Longitudinal study on ageing," Ophthalmic Research, vol. 44, no. 2, pp. 131-139, 2010.
84. T. L. La Rowe, J. A. Mares, D. M. Snodderly, M. L. Klein, B. R. Wooten, and R. Chappell, "Macular pigment density and agerelated maculopathy in the carotenoids in age-related eye disease study. an ancillary study of the women's health initiative," Ophthalmology, vol. 115, no. 5, pp. 876-883.e1, 2008.
85. S. Beatty, I. J. Murray, D. B. Henson, D. Carden, H.-H. Koh, and M. E. Boulton, "Macular pigment and risk for age-related macular degeneration in subjects from a northern European population," Investigative Ophthalmology & Visual Science, vol. 42, no. 2, pp. 439-446, 2001.
86. P. S. Bernstein, D.-Y. Zhao, S. W. Wintch, I. V. Ermakov, R. W. McClane, and W. Gellermann, "Resonance Raman measurement of macular carotenoids in normal subjects and in agerelatedmacular degeneration patients," Ophthalmology, vol. 109, no. 10, pp. 1780-1787, 2002.
87. J. M. Nolan, J. Stack, O. O' Donovan, E. Loane, and S. Beatty, "Risk factors for age-related maculopathy are associated with a relative lack of macular pigment," Experimental Eye Research, vol. 84, no. 1, pp. 61-74, 2007.
88. Age-Related Eye Disease Study Research Group, "A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for agerelated macular degeneration and vision loss: AREDS report no. 8," Archives of Ophthalmology, vol. 119, no. 10, pp. 1417-1436, 2001.
89. E.Y. Chew, T. E. Clemons, E. Agrón et al., "Long-termeffects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35," Ophthalmology, vol. 120, no. 8, pp. 1604.e4-1611.e4, 2013.
90. R. Liu, T. Wang, B. Zhang et al., "Lutein and zeaxanthin supplementation and association with visual function in age-related macular degeneration," Investigative Ophthalmology & Visual Science, vol. 56, no. 1, pp. 252-258, 2014.
91. E. Y. Chew, T. E. Clemons, J. P. Sangiovanni et al., "Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report no. 3," JAMA Ophthalmology, vol. 132, no. 2, pp. 142-149, 2014.
92. D. I. Thurnham, J. M. Nolan, A.N. Howard, and S. Beatty, "Macular response to supplementation with differing xanthophyll formulations in subjects with and without age-related macular degeneration," Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 253, no. 8, pp. 1231-1243, 2015.
93. X. Gong and L. P. Rubin, "Role of macular xanthophylls in prevention of common neovascular retinopathies: retinopathy of prematurity and diabetic retinopathy," Archives of Biochemistry and Biophysics, vol. 572, pp. 40-48, 2015.
94. G. Cavallaro, L. Filippi, P. Bagnoli et al., "The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge," Acta Ophthalmologica, vol. 92, no. 1, pp. 2-20, 2014.
95. A. Hellström, L. E. H. Smith, and O. Dammann, "Retinopathy of prematurity," The Lancet, vol. 382, no. 9902, pp. 1445-1457, 2013.
96. J. C. Rivera, P. Sapieha, J.-S. Joyal et al., "Understanding retinopathy of prematurity: update on pathogenesis," Neonatology, vol. 100, no. 4, pp. 343-353, 2011.
97. L. E. Smith, A.-L. Hard, and A. Hellström, "Thebiology of retinopathy of prematurity: how knowledge of pathogenesis guides treatment," Clinics in Perinatology, vol. 40, no. 2, pp. 201-214, 2013.
98. N. Acar, O. Berdeaux, S. Grégoire et al., "Lipid composition of the human eye: are red blood cells a good mirror of retinal and optic nerve fatty acids?" PLoS ONE, vol. 7, no. 4, Article ID e35102, 2012.
99. E. E. Birch, D. G. Birch, D. R. Hoffman, and R. Uauy, "Dietary essential fatty acid supply and visual acuity development," Investigative Ophthalmology & Visual Science, vol. 33, no. 11, pp. 3242-3253, 1992.
100. C. Kaur, V. Sivakumar, W. S. Foulds, C. D. Luu, and E.-A. Ling, "Cellular and vascular changes in the retina of neonatal rats after an acute exposure to hypoxia," Investigative Ophthalmology & Visual Science, vol. 50, no. 11, pp. 5364-5374, 2009.
101. L. Feeney-Burns, E. S. Hilderbrand, and S. Eldridge, "Aging human RPE:morphometric analysis of macular, equatorial, and peripheral cells," Investigative Ophthalmology & Visual Science, vol. 25, no. 2, pp. 195-200, 1984.
102. G. L. Wing, G. C. Blanchard, and J. J. Weiter, "The topography and age relationship of lipofuscin concentration in the retinal pigment epithelium," Investigative Ophthalmology & Visual Science, vol. 17, no. 7, pp. 601-607, 1978.
103. M. R. Niesman, K. A. Johnson, and J. S. Penn, "Therapeutic effect of liposomal superoxide dismutase in an animal model of retinopathy of prematurity," Neurochemical Research, vol. 22, no. 5, pp. 597-605, 1997.
104. J. S. Penn, B. L. Tolman, and L. E. Bullard, "Effect of a watersoluble vitamin E analog, Trolox C, on retinal vascular development in an animal model of retinopathy of prematurity," Free Radical Biology & Medicine, vol. 22, no. 6, pp. 977-984, 1997.
105. S. Picone, A. Ritieni, A. Fabiano et al., "Arterial cord blood lutein levels in preterm and term healthy newborns are sex and gestational age dependent," Clinical Biochemistry, vol. 45, no. 18, pp. 1558-1563, 2012.
106. S. Perrone, M. Tei, M. Longini et al., "Lipid and protein oxidation in newborn infants after lutein administration," Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 781454, 7 pages, 2014.
107. C. Dani, I. Lori, F. Favelli et al., "Lutein and zeaxanthin supplementation in preterm infants to prevent retinopathy of prematurity: a randomized controlled study," The Journal of Maternal-Fetal & Neonatal Medicine, vol. 25, no. 5, pp. 523-527, 2012.
108. P. Manzoni, R. Guardione, P. Bonetti et al., "Lutein and zeaxanthin supplementation in preterm very low-birth-weight neonates in neonatal intensive care units: a multicenter randomized controlled trial," American Journal of Perinatology, vol. 30, no. 1, pp. 25-32, 2013.
109. C. Romagnoli, C. Giannantonio, F. Cota et al., "A prospective, randomized, double blind study comparing lutein to placebo for reducing occurrence and severity of retinopathy of prematurity," The Journal of Maternal-Fetal & Neonatal Medicine, vol. 24, supplement 1, pp. 147-150, 2011.
110. L. P. Rubin, G. M. Chan, B.M. Barrett-Reis et al., "Effect of carotenoid supplementation on plasma carotenoids, inflammation and visual development in preterm infants," Journal of Perinatology, vol. 32, no. 6, pp. 418-424, 2012.
111. M. Brownlee, "Biochemistry and molecular cell biology of diabetic complications," Nature, vol. 414, no. 6865, pp. 813-820, 2001.
112. M. Brownlee, "The pathobiology of diabetic complications: a unifying mechanism," Diabetes, vol. 54, no. 6, pp. 1615-1625, 2005.
113. M. Nitti, C. d'Abramo, N. Traverso et al., "Central role of PKCδ in glycoxidation-dependent apoptosis of human neurons," Free Radical Biology & Medicine, vol. 38, no. 7, pp. 846-856, 2005.
114. M. Nitti, A. L. Furfaro, N. Traverso et al., "PKC delta and NADPH oxidase in AGE-induced neuronal death," Neuroscience Letters, vol. 416, no. 3, pp. 261-265, 2007.
115. I.G. Obrosova, V. R. Drel, P. Pacher et al., "Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited," Diabetes, vol. 54, no. 12, pp. 3435-3441, 2005.
116. P. Pacher and C. Szabó, "Role of poly(ADP-ribose) polymerase- 1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme," Antioxidants & Redox Signaling, vol. 7, no. 11-12, pp. 1568-1580, 2005.
117. E. Arnal, M. Miranda, S. Johnsen-Soriano et al., "Beneficial effect of docosahexanoic acid and lutein on retinal structural, metabolic, and functional abnormalities in diabetic rats," Current Eye Research, vol. 34, no. 11, pp. 928-938, 2009.
118. R. A. Kowluru, B. Menon, and D. L. Gierhart, "Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats," Investigative Ophthalmology & Visual Science, vol. 49, no. 4, pp. 1645-1651, 2008.
119. M. Miranda, M. Muriach, J. Roma et al., "Oxidative stress in a model of experimental diabetic retinopathy: the utility of peroxinytrite scavengers," Archivos de la Sociedad Espanola de Oftalmologia, vol. 81, no. 1, pp. 27-32, 2006.
120. M. Muriach, F. Bosch-Morell, G. Alexander et al., "Lutein effect on retina and hippocampus of diabetic mice," Free Radical Biology & Medicine, vol. 41, no. 6, pp. 979-984, 2006.
121. M. Sasaki, Y. Ozawa, T. Kurihara et al., "Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes," Diabetologia, vol. 53, no. 5, pp. 971-979, 2010.
122. L. Brazionis, K. Rowley, C. Itsiopoulos, and K. O'dea, "Plasma carotenoids and diabetic retinopathy," The British Journal of Nutrition, vol. 101, no. 2, pp. 270-277, 2009.
123. V. C. Lima, R. B. Rosen, M. Maia et al., "Macular pigment optical density measured by dual-wavelength autofluorescence imaging in diabetic and nondiabetic patients: a comparative study," Investigative Ophthalmology & Visual Science, vol. 51, no. 11, pp. 5840-5845, 2010.
124. B.-J. Hu, Y.-N. Hu, S. Lin, W.-J. Ma, and X.-R. Li, "Application of lutein and zeaxanthin in nonproliferative diabetic retinopathy," International Journal of Ophthalmology, vol. 4, no. 3, pp. 303-306, 2011.
125. P. F. Jacques, L. T. Chylack Jr., S. E. Hankinson et al., "Long-term nutrient intake and early age-related nuclear lens opacities," Archives of Ophthalmology, vol. 119, no. 7, pp. 1009-1019, 2001.
126. M. Kuzniarz, P. Mitchell, R.G. Cumming, and V.M. Flood, "Use of vitamin supplements and cataract: the Blue Mountains Eye study," American Journal of Ophthalmology, vol. 132, no. 1, pp. 19-26, 2001.
127. M. C. Leske, L. T. Chylack Jr., Q. He et al., "Antioxidant vitamins and nuclear opacities: the Longitudinal study of cataract," Ophthalmology, vol. 105, no. 5, pp. 831-836, 1998.
128. M. C. Leske, L. T. Chylack Jr., and S.-Y. Wu, "The lens opacities case-control study. risk factors for cataract," Archives of Ophthalmology, vol. 109, no. 2, pp. 244-251, 1991.
129. J. A. Mares-Perlman, B. J. Lyle, R. Klein et al., "Vitamin supplement use and incident cataracts in a population-based study," Archives of Ophthalmology, vol. 118, no. 11, pp. 1556-1563, 2000.
130. J. M. Seddon, W. G. Christen, J. E. Manson et al., "The use of vitamin supplements and the risk of cataract among US male physicians," American Journal of Public Health, vol. 84, no. 5, pp. 788-792, 1994.
131. K.-J. Yeum, A. Taylor, G. Tang, and R.M. Russell, "Measurement of carotenoids, retinoids, and tocopherols in human lenses," Investigative Ophthalmology & Visual Science, vol. 36, no. 13, pp. 2756-2761, 1995.
132. K.-J. Yeum, F. Shang, W. Schalch, R. M. Russell, and A. Taylor, "Fat-soluble nutrient concentrations in different layers of human cataractous lens," Current Eye Research, vol. 19, no. 6, pp. 502-505, 1999.
133. R. D. Sperduto, T.-S. Hu, R. C. Milton et al., "The Linxian cataract studies: two nutrition intervention trials," Archives of Ophthalmology, vol. 111, no. 9, pp. 1246-1253, 1993.
134. Age-Related Eye Disease Study Research Group, "A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9," Archives of Ophthalmology, vol. 119, no. 10, pp. 1439-1452, 2001.
135. L. Brown, E. B. Rimm, J. M. Seddon et al., "A prospective study of carotenoid intake and risk of cataract extraction in US men," The American Journal of Clinical Nutrition, vol. 70, no. 4, pp. 517-524, 1999.
136. B. J. Lyle, J. A. Mares-Perlman, B. E. K. Klein, R. Klein, and J. L. Greger, "Antioxidant intake and risk of incident age-related nuclear cataracts in the beaver dameye study,"American Journal of Epidemiology, vol. 149, no. 9, pp. 801-809, 1999.
137. C. R. Gale, N. F. Hall, D. I. W. Phillips, and C. N. Martyn, "Plasma antioxidant vitamins and carotenoids and age-related cataract," Ophthalmology, vol. 108, no. 11, pp. 1992-1998, 2001.
138. T. T. J. M. Berendschot, W. M. R. Broekmans, I. A. A. Klöpping-Ketelaars, A. F. M. Kardinaal, G. Van Poppel, and D. Van Norren, "Lens aging in relation to nutritional determinants and possible risk factors for age-related cataract," Archives of Ophthalmology, vol. 120, no. 12, pp. 1732-1737, 2002.
139. H. T. V. Vu, L. Robman, A. Hodge, C. A. McCarty, and H. R. Taylor, "Lutein and zeaxanthin and the risk of cataract: the melbourne visual impairment project," Investigative Ophthalmology &Visual Science, vol. 47, no. 9, pp. 3783-3786, 2006.
140. C. Delcourt, I. Carrìere, M. Delage et al., "Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA study," Investigative Ophthalmology& Visual Science, vol. 47, no. 6, pp. 2329-2335, 2006.
141. W. G. Christen, S. Liu, R. J. Glynn, J. M. Gaziano, and J. E. Buring, "Dietary carotenoids, vitamins C and E, and risk of cataract in women: a prospective study," Archives of Ophthalmology, vol. 126, no. 1, pp. 102-109, 2008.
142. B. Olmedilla, F. Granado, I. Blanco, and M. Vaquero, "Lutein, but not α-tocopherol, supplementation improves visual function in patients with age-related cataracts: a 2-y double-blind, placebo-controlled pilot study," Nutrition, vol. 19, no. 1, pp. 21-24, 2003.